ADVFN Logo ADVFN

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
MaxCyte Inc

MaxCyte Inc (MXCT)

3.26
-0.03
(-0.91%)
Closed March 17 3:00PM
3.26
0.00
( 0.00% )
Pre Market: 6:00AM
Advanced chart

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
3.26
Bid
3.14
Ask
3.75
Volume
-
0.00 Day's Range 0.00
2.76 52 Week Range 5.26
Market Cap
Previous Close
3.26
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
600,752
Shares Outstanding
103,504,571
Dividend Yield
-
PE Ratio
-8.90
Earnings Per Share (EPS)
-0.37
Revenue
41.29M
Net Profit
-37.92M

About MaxCyte Inc

MaxCyte Inc operates in the United States healthcare sector. It develops proprietary electroporation technology, which used blood cells instead of traditional chemical methods to transport medical gene therapies to targeted sites, increasing their safety and efficacy. The company technology finds it... MaxCyte Inc operates in the United States healthcare sector. It develops proprietary electroporation technology, which used blood cells instead of traditional chemical methods to transport medical gene therapies to targeted sites, increasing their safety and efficacy. The company technology finds its use in biotechnology and pharmaceutical firms engaged in cell therapy, including gene editing and immuno-oncology and in drug discovery, development, and biomanufacturing. Its products include MaxCyte STX, VLX, and GT. The company application includes Cell/Gene Therapy, Protein Production, Cell-based Assays, Gene Editing, Cell Line Development, and Viral Vectors/Vaccines. It acquires its income principally from the sale or lease of instruments and processing assemblies. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
MaxCyte Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker MXCT. The last closing price for MaxCyte was US$3.26. Over the last year, MaxCyte shares have traded in a share price range of US$ 2.76 to US$ 5.26.

MaxCyte currently has 103,504,571 shares outstanding. The market capitalization of MaxCyte is US$337.42 million. MaxCyte has a price to earnings ratio (PE ratio) of -8.90.

MXCT Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.16-4.67836257313.423.472.7610615683.23307957CS
4-0.93-22.19570405734.194.212.767355373.44048543CS
12-0.79-19.50617283954.055.152.766007524.04831666CS
26-0.81-19.90171990174.075.152.765548113.88701031CS
52-1.05-24.36194895594.315.262.765043574.07712594CS
156-2.48-43.20557491295.747.762.455615094.54705181CS
260-13.73-80.812242495616.9917.442.455842885.82236381CS

MXCT - Frequently Asked Questions (FAQ)

What is the current MaxCyte share price?
The current share price of MaxCyte is US$ 3.26
How many MaxCyte shares are in issue?
MaxCyte has 103,504,571 shares in issue
What is the market cap of MaxCyte?
The market capitalisation of MaxCyte is USD 337.42M
What is the 1 year trading range for MaxCyte share price?
MaxCyte has traded in the range of US$ 2.76 to US$ 5.26 during the past year
What is the PE ratio of MaxCyte?
The price to earnings ratio of MaxCyte is -8.9
What is the cash to sales ratio of MaxCyte?
The cash to sales ratio of MaxCyte is 8.17
What is the reporting currency for MaxCyte?
MaxCyte reports financial results in USD
What is the latest annual turnover for MaxCyte?
The latest annual turnover of MaxCyte is USD 41.29M
What is the latest annual profit for MaxCyte?
The latest annual profit of MaxCyte is USD -37.92M
What is the registered address of MaxCyte?
The registered address for MaxCyte is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the MaxCyte website address?
The website address for MaxCyte is www.maxcyte.com
Which industry sector does MaxCyte operate in?
MaxCyte operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
RGCRegencell Bioscience Holdings Ltd
US$ 31.61
(70.86%)
370.76k
AFRIForafric Global PLC
US$ 13.69
(59.93%)
15
LGHLWLion Group Holding Ltd
US$ 0.01
(58.73%)
1
SYRSSyros Pharmaceuticals Inc
US$ 0.1348
(57.11%)
26.08M
LEELee Enterprises Inc
US$ 12.99
(51.22%)
145
ATXIAvenue Therapeutics Inc
US$ 0.52
(-38.97%)
95.41k
AGMHAGM Group Holdings Inc
US$ 0.0736
(-30.30%)
5.01M
HYPRHyperfine Inc
US$ 0.9514
(-25.67%)
646.69k
VRPXVirpax Pharmaceuticals Inc
US$ 0.1271
(-24.79%)
253.43k
HLMNHillman Solutions Corporation
US$ 7.01
(-23.56%)
12
SYRSSyros Pharmaceuticals Inc
US$ 0.1335
(55.59%)
26.09M
GNPXGenprex Inc
US$ 0.4665
(16.63%)
20.78M
BONBon Natural Life Ltd
US$ 0.639
(4.31%)
17.13M
LITMSnow Lake Resources Ltd
US$ 0.53795
(29.25%)
13.37M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 7.905
(-5.22%)
5.42M

MXCT Financials

Financials

Discussion

View Full Feed
Investor2014 Investor2014 23 seconds ago
Wow! That's rich from over the pond in the current situation!
AVXL
mrbojangle mrbojangle 1 minute ago
It's been a while since I posted, but I ran across this post on another board this morning and thought you all might be interested. 
Azerbaijan will sign agreements today to explore natural gas in Israeli waters.
A consortium of Socar, BP Plc, and NewMed Energy LP will receive
ZNOG
stocktowatch stocktowatch 2 minutes ago
$PHRRF March 2025 Corporate Presentation
https://www.pharmather.com/uploads/1/2/5/8/125844350/deck_-_phrm_-_1020201.pdf
PHRRF
kgromax kgromax 2 minutes ago
As has been stated before, the cadence of the release of information, and the delay of release in relation to the published date is very interesting. They are definitely a step ahead of the public sphere of knowledge.
All wrong. Old 2022 results, rehashed by a management that has few things t
CYDY
jazz_1 jazz_1 3 minutes ago
https://www.accessnewswire.com/newsroom/en/business-and-professional-services/greene-concepts-inc-marks-over-five-years-of-expansion-and-commu-1000628
INKW
Tree Tree 5 minutes ago
Good morning my little Bracketologists!
RIGATONI RIGATONI 5 minutes ago
$6.01 boom ~Rig
TooFrank TooFrank 5 minutes ago
Yes it is.

Did you read this post?

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175932838
NIO
Tree Tree 5 minutes ago
LOL!!!!
kenjiroo kenjiroo 5 minutes ago
Morning pea, yeah .. tried that before, but it just is not listed (yet) in the apple store here.
TPTW
helpx helpx 5 minutes ago
Tesla has become the enemy and nothing will stop its slide
TSLA
VVVVVV VVVVVV 7 minutes ago
Hey Straightword, it’s a good thing they don’t have to prove infringement to succeed in any of the Antitrust and or RICO Cases!

I know one thing, I wouldn’t want my name associated with any RICO allegations, would you?

LMAO
VPLM
plugger plugger 7 minutes ago
I wrote something here , then an advertisement took over my computer.....this is getting to a regular visit....Trials bring Patience

Good Morning to you Bible Board folks----have a beautiful day
GOD BLESS
TheFollower TheFollower 8 minutes ago
10baggerz: good post.
I'd also add this post for others to be reminded. Thanks to tunnelvisionofplenty.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175831277
NWBO
stocktowatch stocktowatch 8 minutes ago
$ALLR Allarity Therapeutics Announces Presentation of Phase 2 Clinical Data from Ongoing Trial in Advanced Ovarian Cancer Patients at the 2025 Annual Meeting for the Society of Gynecologic Oncology
https://finance.yahoo.com/news/allarity-therapeutics-announces-presentation-phase-120000609.htm
ALLR
peafunke peafunke 9 minutes ago
Morning Ken
Just to be clear, you're searching for the 'vume live' app not just Vume.  
Have you tried going through this website to get the app?
https://vumesuperapp.com/

TPTW
DTGoody DTGoody 9 minutes ago
Very nice article! Just a matter of time before this explodes!
AFFU
MWM MWM 10 minutes ago
Ahh that's what it is, well they are still trading with no premium then. Thanks 
uranium-pinto-beans uranium-pinto-beans 10 minutes ago
🔸 Apple ( $AAPL) lost an appeal in Germany, facing tighter regulations after a long market debate.

🔸 Baidu ( $BIDU) rises on reports Tesla (TSLA) will launch Full Self-Driving (FSD) in China this year, partnering with Baidu. Free FSD trials run March 17–April 16.
AAPL BIDU GETY
bb8675309 bb8675309 11 minutes ago
You should enjoy the country that you live in and leave ours alone.
AVXL
Ranb2khz Ranb2khz 11 minutes ago
Heaven Changes Everything – Big Daddy Weave (with lyrics)

[yt]OzKzoldvaIA[/yt]

https://www.youtube.com/watch?v=OzKzoldvaIA






Investor2014 Investor2014 12 minutes ago
You should be happy about another possible dry powder $AVXL opportunity - my friend!
AVXL
BooDog BooDog 14 minutes ago
$PROK $1.04 pinch setup...
https://stockcharts.com/c-sc/sc?s=PROK&p=D&yr=0&mn=4&dy=10&i=p80904663129&a=1680177097&r=1735588532129 PROK daily
PROK

Your Recent History

Delayed Upgrade Clock